Summit Therapeutics Inc (SMMT)
19.90
-0.06
(-0.30%)
USD |
NASDAQ |
Nov 05, 14:29
Summit Therapeutics Total Assets (Quarterly): 502.85M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 502.85M |
| June 30, 2024 | 341.86M |
| March 31, 2024 | 176.78M |
| December 31, 2023 | 202.95M |
| September 30, 2023 | 218.48M |
| June 30, 2023 | 237.37M |
| March 31, 2023 | 254.90M |
| December 31, 2022 | 664.17M |
| September 30, 2022 | 155.33M |
| June 30, 2022 | 95.72M |
| March 31, 2022 | 116.47M |
| December 31, 2021 | 113.37M |
| September 30, 2021 | 128.67M |
| June 30, 2021 | 145.52M |
| March 31, 2021 | 140.79M |
| December 31, 2020 | 102.50M |
| September 30, 2020 | 56.86M |
| March 31, 2020 | 88.81M |
| October 31, 2019 | 50.76M |
| July 31, 2019 | 58.88M |
| April 30, 2019 | 69.38M |
| January 31, 2019 | 79.53M |
| October 31, 2018 | 56.97M |
| July 31, 2018 | 61.44M |
| April 30, 2018 | 87.76M |
| Date | Value |
|---|---|
| January 31, 2018 | 78.10M |
| October 31, 2017 | 64.30M |
| July 31, 2017 | 54.10M |
| April 30, 2017 | 39.96M |
| January 31, 2017 | 46.98M |
| October 31, 2016 | 52.45M |
| July 31, 2016 | 19.33M |
| April 30, 2016 | 29.52M |
| January 31, 2016 | 35.69M |
| October 31, 2015 | 45.42M |
| July 31, 2015 | 52.43M |
| April 30, 2015 | 57.53M |
| January 31, 2015 | 29.22M |
| October 31, 2014 | 34.10M |
| July 31, 2014 | 39.56M |
| January 31, 2014 | 12.03M |
| July 31, 2013 | 10.23M |
| January 31, 2013 | 6.914M |
| July 31, 2012 | 8.584M |
| July 31, 2012 | 8.584M |
| January 31, 2012 | 6.118M |
| July 31, 2011 | 9.182M |
| January 31, 2011 | 8.056M |
| July 31, 2010 | 14.86M |
| January 31, 2010 | 18.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
56.86M
Minimum
Sep 2020
664.17M
Maximum
Dec 2022
207.97M
Average
150.42M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 112.63B |
| Terns Pharmaceuticals Inc | 230.88M |
| Instil Bio Inc | 294.32M |
| Viking Therapeutics Inc | 937.89M |
| Moderna Inc | 15.68B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 64.93M |
| Shareholders Equity (Quarterly) | 437.92M |